Genetic analysis of beta-thalassemia major and beta-thalassemia intermedia in Brazil

Nenhuma Miniatura disponível
Data
1998-01-01
Autores
Fonseca, Silvana Fahel da [UNIFESP]
Kerbauy, José [UNIFESP]
Escrivao, C.
Figueiredo, Maria Stella [UNIFESP]
Cancado, R.
Arruda, V. R.
Saad, Sara Teresinha Olalla [UNIFESP]
Costa, Fernando Ferreira [UNIFESP]
Orientadores
Tipo
Artigo
Título da Revista
ISSN da Revista
Título de Volume
Resumo
The development of methodologies to identify the molecular lesions responsible for different types of beta-thalassemia has made it possible to correlate these data with clinical and hematological severity. We examined DNA from 35 patients with beta-thalassemia, residents of the State of Sao Paulo, Brazil, for some types of genetic modifying factors: beta-thalassemia mutations, the upstream XmnI (G)y-globin gene polymorphisms, and alpha-globin gene deletions. Additionally, the beta-like gene cluster haplotypes and the presence of the Y-A(T) variant were studied. The following mutations were present in the 70 chromosomes studied: 54.3% codon 39 (C-->T) (beta degrees); 18.6% IVS-I-6 (T-->C (beta(')); 18.6% IVS-I-110 (G-->A) (beta+), and 4.3% IVS-I-1 (G-->T) (beta degrees). Haplotype II was associated with the nonsense mutation at codon 39, haplotype I with the IVS-I-110 and codon 39 mutations, and haplotypes VI and VII with the IVS-I-6 mutation. The XmnI polymorphism was detected in three out of 31 patients studied. No alpha-thalassemia was detected among the thalassemia intermedia patients. The Y-A(T) variant was present in 87.1% of 31 thalassemia patients and was associated with the codon 39/haplotype II and IVS-I-6/haplotype VI mutations. This is the first study of the Brazilian population that has analyzed the beta-thalassemia mutations and of her molecular variants, and has correlated them with the clinical manifestations.
Descrição
Citação
Hemoglobin. New York: Marcel Dekker Inc, v. 22, n. 3, p. 197-207, 1998.
Palavras-chave
Coleções